Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This trial will compare the efficacy of irinotecan/cisplatin and pemetrexed/cisplatin in the second-line treatment of patients with stage IIIB/IV NSCLC
Epistemonikos ID: 7a8677d1472b829f052f3cf4e8af3a8b34416d26
First added on: May 04, 2024